New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group-Reference-Cited by-同舟云学术

New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group

Published:2023-10 Issue: Volume:190 Page:104108
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Catania Chiara,Filippi Andrea Riccardo,Sangalli Claudia,Piperno Gaia,Russano Marco,Greco Carlo,Scotti Vieri,Proto Claudia,Bennati Chiara,Di Pietro Paolo Marzia,Platania Angelo,Olmetto Emanuela,Agustoni Francesco,Teodorani Nazario,Agbaje Vincenzo,Russo Alessandro

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference54 articles.

1. Immunotherapy in non-small cell lung cancer harbouring driver mutations;Addeo;Cancer Treat. Rev.,2021

2. Durvalumab for stage III EGFR-mutated NSCLC after definitive chemoradiotherapy;Aredo;J. Thorac. Oncol.,2021

3. Durvalumab for stage III EGFR-mutated NSCLC after definitive chemoradiotherapy;Aredo;J. Thorac. Oncol.,2021

4. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J. Clin. Oncol.,2010

5. Long-term results of NRG oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III Non-small-cell lung cancer;Bradley;J. Clin. Oncol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer;Annals of Oncology;2024-02